The Alzheimer’s Association International Conference (AAIC) is the world’s largest forum for the dementia research community. IF AVXL is smart they will allow Dr MacFarlane to release the 26 week data at this SCIENTIFIC RESEARCH meeting. This is the only reasonable strategy for communicating the 26 week data-by releasing it at a High Impact, High Visibility, High Visibility High Science meeting that = High Credibility. Just be patient !
I don't know what he said about data availability, or what they hoped to do. What I do know is that it is difficult to know exactly when a researcher will have the data fully collected and cleaned so it can be analyzed. If the data collection/analysis took longer than anticipated then he would have had limited options for presenting the data at a major scientific meeting before AAIC. The are NOT a lot of MAJOR Alzheimers meeting in the first half of the year so the near term options for presentation are limited. Also, keep in mind, the abstract has to be written and submitted prior to a deadline. Then it has to undergo peer review to determine if it will be accepted. The bottom line is that a few months delay to get the data presented at a major scientific meeting is a GOOD THING. The company does not just need positive data, it needs CREDIBLE positive data and the way to get that is have it presented at a major meeting such as AAIC where it can be HEARD BY A LARGE AUDIENCE WITH A LOT OF PRESS COVERAGE !
There is NO WAY the 26 week data will be presented by CEO at an investor meeting in June before the Principal Investigator PRESENTS THE DATA AT A SCIENTIFC MEETING. The good news is that AAIC is held in July. Presentation of scientific PEER REVIEWED MEETING is key to credibility and helps to validate the science.
AAIC is the next major Alzheimers scientific research meeting. Just like cancer companies wait to reveal new data until ASCO Meeting in June, Neuro companies wait to reveal Alzheimers data at AAIC in July.
I believe the 26 week data will be presented at AAIC Meeting in July. This is the next MAJOR INTERNATIONAL SCIENTIFIC MEETING. They company needs to let the scientific community validate the results via peer review. Below are the key criteria for scientific data to be presented at AAIC
- Late-breaking research/newness of information.
- Potential impact on the research community.
- Quality of scientific research.
- Relevance to Alzheimer's disease and related disorders.
- Topics of interest include basic and translational science, diagnosis and prognosis, therapeutics, and public health and psychosocial issues
The deadline for submission was May 2 and presenters will be notified of acceptance by the end of June. Once abstract has been accepted the company will issue a press release saying when and where the data will be presented. JUST LIKE Dr MacFarlance DID LAST YEAR AT AAIC when the great news hit.